·Basic Research· Current
Issue· ·Achieve· ·Search Articles· ·Online Submission· ·About IJO· PMC
Citation: Zhang YH, Li J, Yang
WZ, Xian ZH, Feng QT, Ruan XC. Mitochondrial expression and activity of
P-glycoprotein under oxidative stress in outer blood-retinal barrier. Int J
Ophthalmol 2017;10(7):1055-1063
Mitochondrial expression and activity of P-glycoprotein under oxidative stress
in outer blood-retinal barrier
Yue-Hong
Zhang1, Juan Li2, Wei-Zhong Yang1,
Zhuan-Hua Xian1, Qi-Ting Feng1, Xiang-Cai Ruan3
1Department
of Ophthalmology, First Municipal People’s Hospital of Guangzhou, Affiliated
Hospital of Guangzhou Medical University, Guangzhou 510080, Guangdong Province,
China
2Department
of Ophthalmology, Shaanxi Ophthalmic Medical Center, Xi’an No.4 Hospital,
Affiliated Guangren Hospital, School of Medicine, Xi’an Jiaotong University,
Xi’an 710004, Shaanxi Province, China
3Department
of Anesthesiology, First Municipal People’s Hospital of Guangzhou, Affiliated
Hospital of Guangzhou Medical University, Guangzhou 510080, Guangdong Province,
China
Correspondence
to: Xiang-Cai Ruan. Department of Anesthesiology, First Municipal
People’s Hospital of Guangzhou, Affiliated Hospital of Guangzhou Medical
University, Guangzhou 510080, Guangdong Province, China. xc_ruan@hotmail.com;
xc_ruan@gzhmu.edu.cn
Received: 2016-09-01
Accepted: 2017-02-09
AIM: To
investigate the role of oxidative stress in regulating the functional
expression of P-glycoprotein (P-gp) in mitochondria of D407 cells.
METHODS: D407
cells were exposed to different ranges of concentrations of H2O2.
The mitochondrial location of P-gp in the cells subjected to oxidative stress
was detected by confocal analysis. Expression of P-gp in isolated mitochondria
was assessed by Western blot. The pump activity of P-gp was evaluated by
performing the efflux study on isolated mitochondria with Rhodamine 123
(Rho-123) alone and in the presence of P-gp inhibitor (Tariquidar) using flow
cytometry analysis. The cells were pretreated with 10 mmol/L N-acetylcysteine
(NAC) for 30min before exposing to H2O2, and analyzed the
mitochondrial extracts by Western blot and flow cytometry.
RESULTS:
P-gp was co-localized in the mitochondria by confocal laser scanning
microscopy, and it was also detected in the mitochondria of D407 cells using
Western blot. Exposure to increasing concentrations of H2O2 led
to gradually increased expression and location of P-gp in the mitochondria of
cells. Rho-123 efflux assay showed higher uptake of Rho-123 on isolated
mitochondria in the presence of Tariquidar both in normal and oxidative stress
state. H2O2 up-regulated P-gp in D407 cells, which could
be reversed by NAC treatment.
CONCLUSION: H2O2
could up-regulate the functional expression of P-gp in mitochondria of D407
cells, while antioxidants might suppress oxidative-stress-induced
over-expression of functional P-gp. It is indicative that limiting the
mitochondrial P-gp transport in retinal pigment epithelium cells would be to
improve the effect of mitochondria-targeted antioxidant therapy in age-related
macular degeneration-like retinopathy.
KEYWORDS: P-glycoprotein;
retinal pigment epithelium; oxidative stress; mitochondria
DOI:10.18240/ijo.2017.07.06
Citation: Zhang YH, Li J, Yang WZ, Xian ZH, Feng QT, Ruan
XC. Mitochondrial expression and activity of P-glycoprotein under oxidative
stress in outer blood-retinal barrier. Int J Ophthalmol 2017;10(7):1055-1063
Oxidative stress in the
mitochondria of retinal pigment epithelium (RPE) is thought to play a causative
role in age-related macular degeneration (AMD)[1-5]. RPE is a part of the outer blood-retinal barrier
(BRB). A primary function of RPE is to maintain the metabolic homeostasis of
the retina by removing the waste products and providing nutrients for the
neural retina[6-7]. Dysfunction
and degeneration of RPE by increased oxidative stress contributes to the
irreversible loss of photoreceptors and central vision in AMD[8-9]. One reason that RPE is sensitive to oxidative stress
induced injury and dysfunction is the very high density of mitochondria in RPE.
Mitochondrion is a rich source of reactive oxygen species (ROS) and vulnerable
to oxidative stress, so RPE with abundant mitochondria is destine to be
especially susceptible target of oxidative stress[4].
It has been recognized that mitochondrial dysfunction due to oxidative stress
aggregates in the AMD eyes and the anti-oxidative capacity of RPE from AMD
patients decreases with age[10-11].
There is a need for mitochondria-targeted therapy in AMD-like retinopathy.
Mitochondrial pharmaceutics,
particularly those involving mitochondria-targeted antioxidants, execute
therapeutic potential by maintaining the energy production and ameliorating
apoptosis[12-17]. However,
some mitochondrial medicines may have fewer efficacies than expected due to
their limited access to the mitochondria, although they are accumulated several
hundred-fold into energized mitochondria. One potential mechanism that the
efficacy of these mitochondrial medicines is limited may be the challenging of
the drug efflux pump[18-19].
If these mitochondrial medicines are happened to be substrates of some efflux
pumps, such as P-glycoprotein (P-gp), mitochondria-targeted therapies may be
less efficient.
P-gp is the longest identified
efflux pump, which is encoded by the multidrug resistance (MDR) gene.
Overexpression of P-gp and resistance to apoptosis are correlated well with
MDR, a very common observed molecular mechanism in chemotherapeutic therapy.
P-gp can pump anticancer drugs and other compounds out of the cells, reducing
the intracellular concentration and chemotherapeutic efficacy of these agents[20-21]. P-gp has been also recognized
to be involved in other cell functions such as cellular metabolism and cell
survival[22-24]. It is
generally considered that P-gp expresses on cell surface, but increasingly
growing evidences show the functional localization of P-gp in mitochondria[25-27]. In response to a broad range
of endogenous and xenobiotic stimuli, P-gp is proposed to either pump these
substrates out of mitochondria or pump them into mitochondria for sequestering,
both reducing the effect of substrates in mitochondria[25,28]. Some novel mitochondria-targeting carrier has been
designed to transport drugs to mitochondria as well as limit the effects of
P-gp efflux pump[29]. We propose that P-gp is
present in the mitochondria of RPE cells and may influence mitochondrial
medicines by changing transport across mitochondrial membranes. We therefore
built hydrogen peroxide (H2O2)-induced oxidative stress in
vitro model in D407 cells to mimic RPE dysfunction in AMD-like retinopathy,
and investigated the functional expression of P-gp in mitochondria of D407
cells under oxidative stress conditions. This study will indicate a possible
role of P-gp activity regulation in the mitochondria targeted therapeutic
intervention in AMD.
Cell Culture
and Treatment The human
RPE D407 cells were from the Experimental Animal Center of Sun Yat-Sen
University, Guangzhou, China. Cells were routinely kept in Dulbecco’s modified
Eagle’s medium (DMEM) containing 10% fetal bovine serum and antibiotics (100
U/mL penicillin and 0.1 mg/mL streptomycin) at 37℃ in a 95% air and 5% CO2. All cell culture reagents
were from Gibco BRL (Grand Island, NY, USA). Treatment of D407 cells in this
study included the incubation with fresh medium containing different
concentrations of H2O2 (Sigma-Aldrich, Shanghai, China)
or antioxidant N-acetylcysteine (NAC, Sigma-Aldrich, Shanghai, China) or P-gp
pump inhibitor, Tariquidar (Selleckchem, China).
Measurement
of Reactive Oxygen Species D407 cells
at a density of 1×106 cells/mL were incubated in serum-free medium
containing 10 µmol/L dichloro-dihydro-fluorescein diacetate (Beyotime
Biotechnology, Jiangsu Province, China) for 20min at 37℃ after exposing to varying concentrations of H2O2.
Following washing, cells were collected by trypsinization. Intracellular ROS
was analyzed from the conversion of nonfluorescent dichloro-dihydro-fluorescein
diacetate to its fluorescent derivatives. The fluorescence intensity was
measured at 488 nm excitation and 525 nm emission wavelengths by flow
cytometry.
Immunofluorescence
Assay Cells at a
density of 2000 cells/chamber were seeded onto polylysine-coated glass chamber
slides. Dilute 1 mmol/L MitoTracker Red CMXRos probe (Life technology, USA),
widely used to identify mitochondria, to the final working concentration 100
nmol/L in DMEM. Cells were reacted with MitoTracker probe for 20min, and then
fixed by ice-cold 4% Paraformaldehyde for 15min and permeabilized for 10min in
1% Triton X-100. They were immunolabeled with mouse monoclonal Mdr-1 antibody
(D-11, 1:200 dilution, Santa Cruz Biotechnology, USA) at room temperature for
2h and were washed and incubated for 30min with anti-mouse IgG Alexa flour 488
(1:5000, Life technology, USA), followed by the addition of 4',
6-diamidino-2-phenylindole (ROCH, USA) to stain nucleus. The staining pattern
was visualized using a confocal microscope (Carl Zeiss Jena GmbH, Jena,
Germany).
Preparation
of Isolated Mitochondria from D407 Cells
The preparation of isolated mitochondria was performed using the
mitochondria isolation kit for mammalian cells (Rockford, IL USA). Cells at a
density of 2×106 cells/mL following H2O2 incubation
were collected by centrifugation (850 g for 10min at 4℃) in a 2.0 mL micorocentrifuge tube. Carefully remove and discard
the supernatant, and re-suspend cells in 10 packed cell volumes of buffer (1
mmol/L TrisHCl, pH 7.4, 0.13 mol/L NaCl, 5 mmol/L KCl, 7.5 mmol/L MgCl2).
Pellet cells and decant supernatant, repeat this washing step 2 times.
Resuspend cells in 6 packed cell volumes of homogenization buffer. Transfer
cells to a glass homogenizer and incubate for 10min on ice. Using a tight
pestle, homogenize the cells. Check under the microscope for cell breakage, the
optimum is around 60% which may require 35 strokes. Pour homogenate into a
conical centrifuge tube containing 1 packed cell volume of 2 mol/L sucrose
solution and mixed gently. Pellet unbroken cells, nuclei, and large debris at
700 g for 10min at 4℃ and transfer the supernatant to
another tube. This treatment is repeated twice, transferring the supernatant to
a new tube each time, discarding the pellet. Pellet the mitochondria by
centrifuging at 12 000 g for 15min at 4℃. Resuspend the mitochondrial pellet in 3 packed cell volumes of
mitochondrial suspension buffer (10 mmol/L TrisHCl, pH 6.7, 0.15 mmol/L MgCl2,
0.25 mol/L sucrose, 1 mmol/L PMSF, 1 mmol/L DTT), and centrifuge at 12 000 g
for 5min. Discard the supernatant, and maintain the mitochondrial pellet on ice
before downstream processing.
Western
Blot The proteins
of isolated mitochondria were extracted by resuspending the cells in RIPA
buffer with protease inhibitor, and incubated on ice for 30min. The samples
were cleared by centrifuging at 12 000 g for 5min at 4℃ and supernatants were collected. The protein concentration was
determined using a protein assay kit (Sangon Biotech, Shanghai, China). Equal
amounts of protein were separated by 10% sodium dodecyl sulfate polyacrylamide
gel electropheresis and transferred electrically onto polyvinylidene fluoride
membranes (ROCH, USA) and blocked with 5% non-fat dry milk in Tris-buffered
saline with 0.05% Tween-20. The membranes were probed with mouse monoclonal
antibodies to P-gp (1:200 dilution, Santa Cruz Biotechnology, Santa Cruz, USA)
or voltage-dependent anion channel 1 (VDAC1, 1:100 dilution, Santa Cruz
Biotechnology) or glyceraldehyde-3-phosphate dehydrogenase (GAPDH, 1: 3000,
Santa Cruz Biotechnology) overnight at 4℃. The anti-mouse secondary antibodies (1:5000 dilution; Santa Cruz
Biotechnology) were incubated for 1.5h at room temperature. The immunoreactive
bands were detected with enhanced chemiluminescence kit (Pulilai, Beijing,
China). The gray value of the target band was determined by using the LabWorks
4.6 gel imaging and analysis software (UVP BioImaging Systems). The expression
of VDCA1 was used to normalize levels of
the mitochondrial
P-gp. To exclude the possibility of contamination of mitochondria by cytoplasm,
we also detected the expression of GAPDH which is a loading control and
cytoplasm marker.
Measurement
of Membrane Potential in Mitochondria
The mitochondrial membrane potential (ΔΨm) was estimated in D407
cells using the dye JC-1 (5, 5′, 6, 6′-tetrachloro-1, 1′, 3,
3′-tetraethylbenzimidazole carbocyanine iodide) by flow cytometry. Cells with
80% confluence were incubated for 20min at 37℃ after the corresponding treatment in medium containing 10 µmol/L
JC-1 (Beyotime Biotechnology, Jiangsu Province, China), a lipophilic
fluorescent cation that exists as green fluorescent monomers at a low ΔΨm or as
red fluorescent aggregates at a greater ΔΨm. The cells were then rinsed twice
in PBS and immediately analyzed by flow cytometry. Data were collected at a 529
nm emission for green fluorescence and at 590 nm for red fluorescence. The
green/red fluorescence intensity ratio is expressed as decreased ΔΨm, which
represents the mitochondrial depolarization ratio.
Rhodamine
123 Accumulation Assay P-gp efflux
activity was determined by flow cytometry with intracellular accumulation of
rhodamine 123 (Rho-123, Sigma-Aldrich, Shanghai, China), which has been used as
a typical probe to assess P-gp function in various cells and tissues. D407
cells were pretreated with 10 mmol/L NAC for 30min or 1 µmol/L tariquidar for
1h before exposing of different concentrations of H2O2
for 24h. The optimal dose of tariquidar employed in this study was determined
by the sub-toxic in D407 cells. Tariquidar was added to the medium for 1h and
cells were then maintained in conditioning media at least for another 12h
following medium was removed and then various detections were performed. To
eliminate the influence of ΔΨm and keep Rho-123 out of mitochondria, cells were
treated with the ionophore carbonyl cyanide m-chlorophenylhydrazone (CCCP, 10
µg/mL, Sigma) for 30min to induce the loss of ΔΨm completely. After
depolarization of the ΔΨm using the CCCP, cells were collected by
trypsinization, washed in PBS, and then incubated for 1h at 37℃ in the dark with 500 nmol/L Rho-123. Cells were then washed and
fed with Rho-123-free culture medium. The cultured cells were pelleted at 200 g
for 5min, washed twice in PBS, and then analyzed immediately by flow cytometry
analysis using a BD Accuri C6 flow cytometer. In each experiment, at least 20
000 events were analyzed. All experiments used six wells per condition and were
repeated on two to three separate occasions. The mean fluorescence intensity in
arbitrary units was used for data presentation.
Statistical
Analysis Data were
presented as the mean±SE and analyzed using the SPSS package for Windows
(version 17.0). The differences between data sets were analyzed by a one-way
ANOVA and P value less than 0.05 was considered to be statistically
significant.
H2O2-induced
Oxidative Stress in D407 Cells The
oxidative stress state in D407 cells following exposure to different
concentrations of H2O2 was determined by detecting the
intracellular ROS level, indicated by DCF fluorescence using flow cytometry. As
shown in Figure 1, the intracellular ROS level was increased in a
concentration-dependent manner after exposing D407 cells to varying
concentrations of H2O2 for 24h.
Figure 1 H2O2
increases ROS production in D407 cells in a dose-dependent manner D407 cells subjected to varying
concentrations of H2O2 for 24h were loaded with DCFH-DA
and the intracellular ROS level was measured by flow cytometry. Results shown
are the mean±SE of three separate experiments performed in triplicate.
Treatment with H2O2 for 24h at a concentration range of 0
to 800 µmol/L caused a linear rise in ROS level and reached a maximum at 800
µmol/L in D407 cells. aP<0.05, bP<0.01
versus CTL for one-way ANOVA. CTL: Untreated cells.
Mitochondrial
Location and Expression of P-glycoprotein in D407 Cells Subjected to Oxidative
Stress Figure 2A is
the confocal microscopic picture presenting the mitochondrial location of P-gp
in D407 cells subjected to oxidative stress. We found a visible but very faint
overlap of P-gp and mitochondria fluorescence in untreated cells, indicating
the colocalization of P-gp and mitochondria in D407 cells. A gradually
increasing overlap of P-gp and mitochondria fluorescence was found in cells
exposure to increased concentration of H2O2, indicating
that P-gp mitochondrial expression increases with the increase of H2O2
exposure concentration. We next examined the P-gp expression in the
mitochondria of D407 cells under oxidative stress state. The mitochondrial
proteins of D407 cells were extracted after exposing to 0-800 µmol/L H2O2
and P-gp expression was analyzed by Western blot. Figure 2B shows that
P-gp expression was observed in the mitochondrial extracts of untreated D407
cells and gradually increased expressions were observed in the increasing
exposure concentrations of H2O2. No expression of GAPDH
was observed in all samples.
Figure 2
Mitochondrial expression and location of P-gp in untreated and H2O2-incubated
D407 cells A: Representative
confocal micrographs of D407 monolayers showed that D407 cells have exact
overlapping P-gp staining (green) and mitochondria staining (red), indicating
colocalization of P-gp and mitochondria (as shown in white arrowhead); B: A
representative Western blot picture showed the alterations of mitochondrial
P-gp in translational level in D407 cells after exposing to varying
concentration of H2O2 for 24h. VDAC1 was used as the
internal loading control of mitochondrial proteins and GAPDH was used as a
cytoplasm marker. The relative protein expression was expressed as the gray
value ratio of target protein to respective VDCA1. The average expression of
each protein was calculated from three independent experiments. aP<0.05,
bP<0.01 versus CTL for one-way ANOVA. CTL: Untreated
cells.
Effect of
Oxidative Stress on the Activity of P-glycoprotein in Mitochondria of D407
Cells To excel the
influence of mitochondrial integrity destruction induced by oxidative stress on
P-gp activity detection, we first measured the alterations of ΔΨm using flow
cytometry (Figure 3). When cells were exposed to 100 or 200 µmol/L H2O2,
the ΔΨm had only a slight decrease (both P>0.05 when comparing to
untreated cells) which indicates that the mitochondrial integrity has not been
significantly damaged by exposure to H2O2 less than 200
µmol/L for 24h. When cells were exposed to 400 or 800 µmol/L H2O2
for 24h, the levels of ΔΨm were significantly decreased (both P<0.05
when comparing to untreated cells). To further exclude cytotoxic effects, the
CCK-8 assay was performed. We found that the cell viability was 82.16%±5.03%
when incubated with 200 µmol/L H2O2 for 24h. Pursuant to
ISO 10993-5, percentages of cell viability above 80% are considered as
non-cytotoxicity. We therefore chose cells exposure to 200 µmol/L H2O2
to investigate the effects of oxidative stress on P-gp activity in mitochondria
of D407 cells. Figure 4 showed that in untreated cells, the intracellular
Rho-123 fluorescence intensity was 22.31%±1.15% and it was increased to
33.98%±1.98% after P-gp activity was inhibited by 1 µmol/L tariquidar
pretreatment for 1h (P<0.05). When cells were treated with 200 µmol/L
H2O2 for 24h or combined pretreatment with 1 µmol/L
tariquidar for 1h, the intracellular Rho-123 fluorescence intensity was
11.20%±1.01% and 18.10%±0.98%, respectively (P<0.05). These results
indicate that the functional expression of P-gp be detected in the normal
mitochondria of D407 cells and its functional expression was increased under
oxidative stress state.
Figure 3
Changes of ΔΨm induced by H2O2 incubation in D407
cells A: The
changes of ΔΨm induced by H2O2 incubation in D407 cells
were detected by flow cytometry. JC-1 was a ΔΨm indicator which could be used
to demonstrate the changes in ΔΨm. The dye fluoresces red when it aggregates in
cells with high ΔΨm, whereas it fluoresces green in cells with low ΔΨm. The
green/red fluorescence intensity ratio is expressed as decreased ΔΨm, which
represents the mitochondrial depolarization ratio; B: Quantitative
densitometric analysis of the decreased ΔΨm by exposure to increasing
concentrations of H2O2 was performed in three independent
experiments. aP<0.05, bP<0.01 versus
CTL for one-way ANOVA. CTL: Untreated cells.
Figure 4
Effect of oxidative stress on the activity of P-gp in mitochondria of D407
cells D407 cells
were treated with 200 μmol/L H2O2 alone or in combination
with 1 μmol/L of tariquidar (1h prior to H2O2 treatment)
for up to 24h. Untreated cells were set as the control (CTL). The activity of
P-gp was determined by measuring the intracellular Rho-123 fluorescence
intensity using flow cytometry. Data are the mean±SE of three separate
experiments. aP<0.05.
Involvement
of Antioxidants in the Regulation of P-glycoprotein Functional Expression in
Mitochondria of D407 Cells To further
determine whether antioxidants could change the functional expression of P-gp
in mitochondria of D407 cells, we pretreated cells with 10 mmol/L NAC (a ROS
scavenger) for 30min before exposing D407 cells to H2O2,
and analyzed the mitochondrial extracts by Western blot and flow cytometry. The
pretreatment of NAC decreased the intracellular ROS level when comparing to
cells exposure to H2O2 (data not shown). In Figure 5A,
the Western blot result showed that P-gp expression was increased after 200
µmol/L H2O2 exposure while its expression was decreased
after NAC pretreatment. Rho-123 accumulation assay further showed that H2O2
treatment induced a significant decrease in the fluorescence intensity of
intracellular Rho-123, indicative of an increased P-gp function. As expected,
the Rho-123 retention was increased with NAC pretreatment before exposure of
200 µmol/L H2O2 when compared with H2O2
alone, but did not fully return to the level of the control, untreated cultures
(Figure 5B). These results indicate that the antioxidant may be involved in the
regulation of P-gp functional expression in D407 cells.
Figure 5
Effects of antioxidants on the functional expression of P-gp in mitochondria of
D407 cells D407 cells
were treated with 200 μmol/L H2O2 alone or in combination
with 10 mmol/L NAC (30min prior to H2O2 treatment) for up
to 24h. Untreated cells were set as the control (CTL). The mitochondrial
expression of P-gp was detected by Western blot and the activity of P-gp was
determined by measuring intracellular Rho-123 accumulations by flow cytometry.
A: A representative Western blot image shows the mitochondrial expression of
P-gp. VDAC1 was used as the internal loading control of mitochondrial proteins
and GAPDH was used as a cytoplasm marker; B: Quantitative densitometric
analysis of the mean fluorescence intensity of intracellular Rho-123 following
different treatment was performed in three independent experiments. aP<0.05
versus CTL for one-way ANOVA.
DISCUSSION
Mitochondrion is becoming an
attractive target for drug-delivery in many oxidative stress-induced diseases[30]. It remains elusive
that whether the mitochondrial drug-delivery executes less therapeutic
potential than expected due to the disturbance of drug efflux pump. We
therefore conducted this study to investigate the functional expression of P-gp
in mitochondria of human D407 RPE cells under normal and oxidative stress
conditions and its influence to the drug-delivery across mitochondrial
membranes. Here we demonstrated the mitochondrial presence of P-gp in the
untreated D407 cells and increased mitochondrial expression under oxidative
stress conditions. The efflux assay detected by quantifying the fluorescence
intensity of intracellular Rho-123 shows that H2O2-exposed
cells have increased transport of Rho-123 across mitochondrial membranes than
untreated cells. In addition, administration of the antioxidant NAC led to the
down-regulation of P-gp functional expression in mitochondria of H2O2-exposed
D407 cells.
Age is the strongest risk factor
for AMD[6] and the oxidative stress is believed to
be a primary contributor to the pathogenesis of AMD[3].
Oxidative stress sensitizes RPE cells to injury and mediates the RPE cells
dysfunction, so growing increasing studies on the AMD pathogenesis have been
focused on defects in RPE function induced by oxidative stress[31-32]. The sources of oxidative
stress in RPE cells are diverse. High oxygen tension exposure from the
choriocapillaris, long-term sunlight exposure and excess accumulation of
lipofuscin are all significant source of oxidative stress to the RPE, which can
lead to destruction of the RPE mitochondrial network and induce further
pathological cascades of toxicity, inflammation and neurodegeneration process[33-34]. Although some protective
mechanisms work in RPE during the early phases of AMD, mitochondria are
vulnerable to oxidative stress[4]. We chose the
point of mitochondrial network damage during oxidative stress in RPE cells
because of the evidences that mitochondrial damage in AMD eyes parallels
disease severity[35] and eyes obtained postmortem
from AMD patients have more obvious free radical damage to mitochondria of RPE
cells than controls[36].
Expression of P-gp efflux
transporter has been detected in different RPE models including primary RPE
cells and secondary ARPE-19 and D407 RPE cell lines. It was indicated a
different efflux transporter expression profile in the different RPE model.
Constable et al[37] showed that P-gp was
expressed in D407 cells but was not in ARPE-19 cells. Chen et al[38] found a significantly different efflux transporter
expression profile in ARPE-19 cells when comparing other RPE models and
suggested to use ARPE-19 with caution in the efflux transporter research. However,
Mannermaa et al[39] thought that ARPE-19
and primary RPE cells had similar efflux protein profile. We think this
discrepancy from different laboratory may be caused by the different process of
cell culture and cell culture materials such as P-gp substrate and inhibitor.
We previously identified expression of P-gp efflux transporter in our
laboratory on human D407 RPE cell line[40-41].
To see from these previously published literatures, we chose D407 cells to
investigate the efflux pump in mitochondria of outer BRB in the present study.
We demonstrated the mitochondrial localization and expression of P-gp in D407
cells by cellular staining assays and Western blot. In obtained confocal
microscopic pictures, the exact overlapping P-gp (green) and mitochondria
staining (red) indicates colocalization of P-gp and mitochondria in D407 cells.
Purified mitochondria were isolated from D407 cells and the visible band of
about 170 kDa following reacting with anti-P-gp antibody further indicated the
presence of P-gp on the mitochondria of D407 cells. The functional expression
of P-gp in mitochondria has been increasingly recognized[25,27]. However, some researchers queried the location of
P-gp in the mitochondrial membranes and they attributed the presence of P-gp in
the mitochondrial fraction to the plasma membrane contamination[42]. To expel the possibility of false positive induced
by contaminated plasma membrane fractions, we chose both VDAC1 and GAPDH as the
internal loading controls. VDAC1 was used as the internal loading control of
mitochondrial proteins and GAPDH was used as a cytoplasm marker. Our findings
showed the negative GAPDH expression in isolated mitochondria, which indicated
that the isolated mitochondria had not been contaminated by plasma membrane
fractions.
We found that the intracellular
ROS levels gradually increased in response to increased H2O2
concentration. Accordingly, P-gp expression in mitochondria also increased with
the increased oxidative stress. P-gp expresses in a wide range of excretory and
barrier tissues and it is proposed that P-gp serves a protective function in
these tissues by limiting the absorption and distribution of harmful
xenobiotics[43]. Induction of P-gp activity is
becoming a new therapeutic focus to limit the toxicity caused by its substrates[44]. Alterations in P-gp functional expression following
H2O2 exposure have been found in several tissues and cell
lines and the potential role of P-gp under oxidative stress in these in
vitro models of H2O2 exposure is also indicated. In
most of the reports, P-gp expression was up-regulated after exposure of H2O2[45-46], while only few reported the
down-regulated expression[47]. It was proposed to
be relative between the amount of ROS and P-gp expression following H2O2
exposure in these published literatures. Because RPE is functionally very
similar to the blood-brain barrier (BBB), we focused on some investigations of
P-gp in BBB and found that consistent with some of the reports, the finding
that up-regulated P-gp expression parallels with the increased ROS generation
in our study was also found in brain endothelial cells[46,48].
In some published literatures, it
is proposed that P-gp executes the protective effects from oxidative injury
might be realized by activating the antioxidant defenses or up regulating some
protective anti-oxidative signal pathways[23-25]. It needs further investigation whether P-gp has a
specific role in regulating the caspase dependent apoptotic pathway or not in
RPE cells. In our study, the fact that NAC attenuated P-gp expression induced
by H2O2 indicates that the altered P-gp expression might
affect the transport of P-gp substrates in RPE cells under conditions of
oxidative stress. Another indication of our findings was that the oxidative
stress in RPE may induce P-gp functional expression to an extent, but the
excessive oxidative damage might increase difficulties in protection against
toxicity caused by its substrates or alteration pharmacokinetics of therapeutic
drugs targeted to the retinopathies.
In summary, we investigated the
location and expression of P-gp in mitochondria of D407 cells under oxidative
stress conditions. One implication of our study is to propose a potential role
of P-gp in the mitochondria targeted therapeutic intervention by changing drug
transport across mitochondrial membranes.
another implication is to propose the necessity of concurrent
application of antioxidant in limiting the mitochondrial P-gp transport and
improving the effect of mitochondria-targeted therapy in AMD-like retinopathy.
Foundations: Supported by National
Natural Science Foundation of China (No.81400424); Guangdong Medical Science Foundation (No.A2015151).
Conflicts of Interest: Zhang YH,
None; Li J, None; Yang WZ, None; Xian ZH, None; Feng
QT, None; Ruan XC, None.
1 Cai L, Liao HF, Zhang XJ, Shao Y, Xu M, Yi JL. Acetylcholinesterase
function in apoptotic retina pigment epithelial cells induced by H2O2.
Int J Ophthalmol 2013;6(6):772-777. [PMC free article] [PubMed]
2 Mao H, Seo SJ, Biswal MR, Li H, Conners M, Nandyala A, Jones K, Le YZ,
Lewin AS. Mitochondrial oxidative stress in the retinal pigment epithelium
leads to localized retinal degeneration. Invest
Ophthalmol Vis Sci 2014;55(7):4613-4627. [CrossRef] [PMC free article] [PubMed]
3 Plafker SM, O'Mealey GB, Szweda LI. Mechanisms for countering
oxidative stress and damage in retinal pigment epithelium. Int Rev Cell Mol Biol 2012;298:135-177. [CrossRef] [PMC free article] [PubMed]
4 Cano M, Wang L, Wan J, Barnett BP, Ebrahimi K, Qian J, Handa JT.
Oxidative stress induces mitochondrial dysfunction and a protective unfolded
protein response in RPE cells. Free Radic
Biol Med 2014;69:1-14. [CrossRef] [PMC free article] [PubMed]
5 Shen Y, Zhuang P, Xiao T, Chiou GC. Effect of cytokeratin 17 on
retinal pigment epithelium degeneration and choroidal neovascularization. Int J Ophthalmol 2016;9(3):363-368. [PMC free article] [PubMed]
6 Chopdar A, Chakravarthy U, Verma D. Age related macular degeneration. BMJ 2003;326(7387):485-488. [CrossRef] [PMC free article] [PubMed]
7 Simó R, Villarroel M, Corraliza L, Hernandez C, Garcia-Ramirez M. The
retinal pigment epithelium: something more than a constituent of the
blood-retinal barrier-implications for the pathogenesis of diabetic
retinopathy. J Biomed Biotechnol
2010;2010:190724. [CrossRef] [PMC free article] [PubMed]
9 Hytti M, Piippo N, Salminen A, Honkakoski P, Kaarniranta K, Kauppinen
A. Quercetin alleviates 4-hydroxynonenal-induced cytotoxicity and inflammation
in ARPE-19 cells. Exp Eye Res
2015;132:208-215. [CrossRef] [PubMed]
10 Nowak JZ. AMD-the retinal disease with an unprecised
etiopathogenesis: in search of effective therapeutics. Acta Pol Pharm 2014;71(6):900-916. [PubMed]
11 Joseph K, Kulik L, Coughlin B, Kunchithapautham K, Bandyopadhyay M, Thiel
S, Thielens NM, Holers VM, Rohrer B. Oxidative stress sensitizes retinal
pigmented epithelial (RPE) cells to complement-mediated injury in a natural
antibody-, lectin pathway-, and phospholipid epitope-dependent manner. J Biol Chem 2013;288(18):12753-12765. [CrossRef] [PMC free article] [PubMed]
12 Saprunova VB, Lelekova MA, Kolosova NG, Bakeeva LE. SkQ1 slows
development of age-dependent destructive processes in retina and vascular layer
of eyes of wistar and OXYS rats. Biochemistry
(Mosc) 2012;77(6):648-658. [CrossRef] [PubMed]
13 Markovets AM, Fursova AZ, Kolosova NG. Therapeutic action of the
mitochondria-targeted antioxidant SkQ1 on retinopathy in OXYS rats linked with
improvement of VEGF and PEDF gene expression. PLoS One 2011;6(7):e21682. [CrossRef] [PMC free article] [PubMed]
14 Jia L, Liu Z, Sun L, Miller SS, Ames BN, Cotman CW, Liu J. Acrolein,
a toxicant in cigarette smoke, causes oxidative damage and mitochondrial
dysfunction in RPE cells: protection by (R)-alpha-lipoic acid. Invest Ophthalmol Vis Sci
2007;48(1):339-348. [CrossRef] [PMC free article] [PubMed]
15 Apostolova N, Victor VM. Molecular strategies for targeting
antioxidants to mitochondria: therapeutic implications. Antioxid Redox Signal 2015; 22(8):686-729. [CrossRef] [PMC free article] [PubMed]
16 Escobales N, Nuñez RE, Jang S, Parodi-Rullan R, Ayala-Peña S, Sacher
JR, Skoda EM, Wipf P, Frontera W, Javadov S. Mitochondria-targeted ROS
scavenger improves post-ischemic recovery of cardiac function and attenuates
mitochondrial abnormalities in aged rats. J
Mol Cell Cardiol 2014;77:136-146. [CrossRef] [PMC free article] [PubMed]
17 Dranka BP, Gifford A, McAllister D, Zielonka J, Joseph J, O'Hara CL,
Stucky CL, Kanthasamy AG, Kalyanaraman B. A novel mitochondrially-targeted
apocynin derivative prevents hyposmia and loss of motor function in the
leucine-rich repeat kinase 2 [LRRK2(R1441G)] transgenic mouse model of
Parkinson's disease. Neurosci Lett
2014;583:159-164. [CrossRef] [PMC free article] [PubMed]
18 Porteous CM, Menon DK, Aigbirhio FI, Smith RA, Murphy MP.
P-glycoprotein (Mdr1a/1b) and breast cancer resistance protein (Bcrp) decrease
the uptake of hydrophobic alkyl triphenylphosphonium cations by the brain. Biochim Biophys Acta
2013;1830(6):3458-3465. [CrossRef] [PMC free article] [PubMed]
19 Fetisova EK, Avetisyan AV, Izyumov DS, Korotetskaya MV, Chernyak BV,
Skulachev VP. Mitochondria-targeted antioxidant SkQR1 selectively protects MDR
(Pgp 170)-negative cells against oxidative stress. FEBS Lett 2010;584(3):562-566. [CrossRef] [PubMed]
20 Anand BS, Dey S, Mitra AK. Current prodrug strategies via membrane
transporters/receptors. Expert Opin Biol
Ther 2002;2(6):607-620. [CrossRef] [PubMed]
21 Gottesman MM. Mechanisms of cancer drug resistance. Annu Rev Med 2002;53:615-627. [CrossRef] [PubMed]
22 Guenova ML, Balatzenko GN, Nikolova VR, Spassov BV, Konstantinov SM.
An anti-apoptotic pattern correlates with multidrug resistance in acute myeloid
leukemia patients: a comparative study of active caspase-3, cleaved PARPs,
Bcl-2, Survivin and MDR1 gene. Hematology
2010;15(3):135-143. [CrossRef] [PubMed]
23 Tainton KM, Smyth MJ, Jackson JT, Tanner JE, Cerruti L, Jane SM,
Darcy PK, Johnstone RW. Mutational analysis of P-glycoprotein: suppression of
caspase activation in the absence of ATP-dependent drug efflux. Cell Death Differ 2004;11(9):1028-1037.
[CrossRef] [PubMed]
24 Mantovani I, Cappellini A, Tazzari PL, Papa V, Cocco L, Martelli AM.
Caspase-dependent cleavage of 170-kDa P-glycoprotein during apoptosis of human
T-lymphoblastoid CEM cells. J Cell
Physiol 2006;207(3): 836-844. [CrossRef] [PubMed]
25 Solazzo M, Fantappiè O, Lasagna N, Sassoli C, Nosi D, Mazzanti R.
P-gp localization in mitochondria and its functional characterization in
multiple drug-resistant cell lines. Exp
Cell Res 2006;312(20):4070-4078. [CrossRef] [PubMed]
26 Barot M, Gokulgandhi MR, Pal D, Mitra AK. Mitochondrial localization
of P-glycoprotein and peptide transporters in corneal epithelial cells-novel
strategies for intracellular drug targeting. Exp Eye Res 2013;106:47-54. [CrossRef] [PMC free article] [PubMed]
27 Munteanu E, Verdier M, Grandjean-Forestier F, Stenger C,
Jayat-Vignoles C, Huet S, Robert J, Ratinaud MH. Mitochondrial localization and
activity of P-glycoprotein in doxorubicin-resistant K562 cells. Biochem Pharmacol 2006;71(8):1162-1174.
[CrossRef] [PubMed]
28 Shen Y, Chu Y, Yang Y, Wang Z. Mitochondrial localization of
P-glycoprotein in the human breast cancer cell line MCF-7/ADM and its
functional characterization. Oncol Rep
2012;27(5):1535-1540. [PubMed]
29 Han J, Lee TH, Tung CH, Lee DY. Design and synthesis of a
mitochondria-targeting carrier for small molecule drugs. Org Biomol Chem 2014;12(48):9793-9796. [CrossRef] [PubMed]
30 Anders MW, Robotham JL, Sheu SS. Mitochondria: new drug targets for
oxidative stress-induced diseases. Expert
Opin Drug Metab Toxicol 2006;2(1):71-79. [CrossRef] [PubMed]
31 Shen JK, Dong A, Hackett SF, Bell WR, Green WR, Campochiaro PA.
Oxidative damage in age-related macular degeneration. Histol Histopathol 2007;22(12):1301-1308. [PubMed]
32 Miter SK, Song C, Qi X, Mao H, Rao H, Akin D, Lewin A, Grant M, Dunn
W Jr, Ding J, Bowes Rickman C, Boulton M. Dysregulated autophagy in the RPE is
associated with increased susceptibility to oxidative stress and AMD. Autophagy 2014;10(11):1989-2005. [CrossRef] [PMC free article] [PubMed]
33 Ebrahimi KB, Fijalkowski N, Cano M, Handa JT. Decreased membrane
complement regulators in the retinal pigmented epithelium contributes to
age-related macular degeneration. J
Pathol 2013;229(5):729-742. [CrossRef] [PMC free article] [PubMed]
34 Thurman JM, Renner B, Kunchithapautham K, Ferreira VP, Pangburn MK,
Ablonczy Z, Tomlinson S, Holers VM, Rohrer B. Oxidative stress renders retinal
pigment epithelial cells susceptible to complement-mediated injury. J Biol Chem 2009;284(25):16939-16947. [CrossRef] [PMC free article] [PubMed]
35 Lin H, Xu H, Liang FQ, Liang H, Gupta P, Havey AN, Boulton ME, Godley
BF. Mitochondrial DNA damage and repair in RPE associated with aging and
age-related macular degeneration. Invest
Ophthalmol Vis Sci 2011;52(6):3521-3529. [CrossRef] [PMC free article] [PubMed]
36 Karunadharma PP, Nordgaard CL, Olsen TW, Ferrington DA. Mitochondrial
DNA damage as a potential mechanism for age-related macular degeneration. Invest Ophthalmol Vis Sci
2010;51(11):5470-5479. [CrossRef] [PMC free article] [PubMed]
37 Constable PA, Lawrenson JG, Dolman DE, Arden GB, Abbott NJ.
P-Glycoprotein expression in human retinal pigment epithelium cell lines. Exp Eye Res 2006;83(1):24-30. [CrossRef] [PubMed]
38 Chen P, Chen H, Zang X, Chen M, Jiang H, Han S, Wu X. Expression of
efflux transporters in human ocular tissues. Drug Metab Dispos 2013; 41(11):1934-1948. [CrossRef] [PubMed]
39 Mannermaa E, Vellonen KS, Ryhanen T, Kokkonen K, Ranta VP,
Kaarniranta K, Urtti A. Efflux protein expression in human retinal pigment
epithelium cell lines. Pharm Res 2009;26(7):1785-1791.
[CrossRef] [PubMed]
40 Zhang Y, Lu M, Sun X, Li C, Kuang X, Ruan X. Expression and activity
of p-glycoprotein elevated by dexamethasone in cultured retinal pigment
epithelium involve glucocorticoid receptor and pregnane X receptor. Invest Ophthalmol Vis Sci
2012;53(7):3508-3515. [CrossRef] [PubMed]
41 Zhang Y, Li C, Sun X, Kuang X, Ruan X. High glucose decreases
expression and activity of p-glycoprotein in cultured human retinal pigment
epithelium possibly through iNOS induction. PLoS
One 2012;7(2):e31631. [CrossRef] [PMC free article] [PubMed]
42 Paterson JK, Gottesman MM. P-Glycoprotein is not present in
mitochondrial membranes. Exp Cell Res
2007;313(14):3100-3105. [CrossRef] [PMC free article] [PubMed]
43 Nawa A, Fujita Hamabe W, Tokuyama S. Inducible nitric oxide
synthase-mediated decrease of intestinal P-glycoprotein expression under
streptozotocin-induced diabetic conditions. Life
Sci 2010;86(11-12):402-409. [CrossRef] [PubMed]
44 Silva R, Vilas-Boas V, Carmo H, Dinis-Oliveira RJ, Carvalho F, de
Lourdes Bastos M, Remião F. Modulation of P-glycoprotein efflux pump: induction
and activation as a therapeutic strategy. Pharmacol
Ther 2015;149:1-123. [CrossRef] [PubMed]
45 Laberge RM, Ambadipudi R, Georges E. P-glycoprotein (ABCB1) modulates
collateral sensitivity of a multidrug resistant cell line to verapamil. Arch Biochem Biophys
2009;491(1-2):53-60. [CrossRef] [PubMed]
46 Robertson SJ, Kania KD, Hladky SB, Barrand MA. P-glycoprotein
expression in immortalised rat brain endothelial cells: comparisons following
exogenously applied hydrogen peroxide and after hypoxia-reoxygenation. J Neurochem 2009;111(1):132-141. [CrossRef] [PubMed]
47 Terada Y, Ogura J, Tsujimoto T, Kuwayama K, Koizumi T, Sasaki S,
Maruyama H, Kobayashi M, Yamaguchi H, Iseki K. Intestinal P-glycoprotein
expression is multimodally regulated by intestinal ischemia-reperfusion. J Pharm Pharm Sci 2014;17(2):266-276. [CrossRef]
48 Nwaozuzu OM, Sellers LA, Barrand MA. Signalling pathways influencing
basal and H(2)O(2)-induced P-glycoprotein expression in endothelial cells
derived from the blood-brain barrier. J Neurochem 2003;87(4):1043-1051. [CrossRef]